Cargando…
Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
Alzheimer’s disease (AD) is the most common dementia in the industrialized world, with prevalence rates well over 30% in the over 80-years-old population. The dementia causes enormous costs to the social healthcare systems, as well as personal tragedies for the patients, families and caregivers. AD...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681567/ https://www.ncbi.nlm.nih.gov/pubmed/23663286 http://dx.doi.org/10.1186/1742-4933-10-18 |